Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)

Jacques, R.M., Boonen, S., Cosman, F. et al. (4 more authors) (2012) Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT). Journal of Bone and Mineral Research, 27 (8). 1627 - 1634. ISSN 1523-4681

Abstract

Metadata

Authors/Creators:
  • Jacques, R.M.
  • Boonen, S.
  • Cosman, F.
  • Reid, I.R.
  • Bauer, D.C.
  • Black, D.M.
  • Eastell, R.
Copyright, Publisher and Additional Information: © 2012 American Society for Bone and Mineral Research. This is an author produced version of a paper subsequently published in Journal of Bone and Mineral Research. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: ZOLEDRONIC ACID; BONE MINERAL DENSITY; PINP; FRACTURE; SURROGATE; PERCENT OF TREATMENT EFFECT EXPLAINED
Dates:
  • Published: 17 July 2012
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Human Metabolism (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 08 Apr 2015 10:38
Last Modified: 29 Mar 2018 00:14
Published Version: http://dx.doi.org/10.1002/jbmr.1644
Status: Published
Publisher: Wiley Subscription Services, Inc., A Wiley Company
Refereed: Yes
Identification Number: https://doi.org/10.1002/jbmr.1644

Share / Export

Statistics